Compounds > papaverine

papaverine and temozolomide

papaverine has been researched along with temozolomide in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Akasaki, Y; Ichimura, K; Inada, M; Kobayashi, K; Sato, A; Shindo, M; Tanuma, SI; Yamamoto, Y	1
Akasaki, Y; Ichimura, K; Inada, M; Sato, A; Shindo, M; Tanuma, SI; Yamamoto, Y	1

Reviews

1 review(s) available for papaverine and temozolomide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

4 other study(ies) available for papaverine and temozolomide

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells. PloS one, 2019, Volume: 14, Issue:5 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Heterografts; HMGB1 Protein; Humans; Mice; Opiate Alkaloids; Papaverine; Receptor for Advanced Glycation End Products; Temozolomide	2019
Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth. Anticancer research, 2019, Volume: 39, Issue:12 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; HMGB1 Protein; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Papaverine; Radiation Tolerance; Receptor for Advanced Glycation End Products; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays	2019